188
Views
1
CrossRef citations to date
0
Altmetric
Review

Ultradeformable phospholipid vesicles as a drug delivery system: a review

&
Pages 55-69 | Published online: 01 Dec 2015

References

  • Morrow DIJ, McCarron PA, Woolfson AD, Donnelly RF. Innovative strategies for enhancing topical and transdermal drug delivery. Open Drug Delivery J. 2007;1:36–59.
  • Hadgraft J, Guy R, editors. Transdermal Drug Delivery. Developmental Issues and Research Initiatives. New York: Marcel Dekker; 1989.
  • Bouwstra JA, Ponec M. The skin barrier in healthy and diseased state. Biochim Biophys Acta. 2006;1758:2020–2080.
  • Bangham AD, Horne RW. Negative staining of phospholipids and their structured modification by surface active agents as observed in the electron microscope. J Mol Biol. 1964;8:660–668.
  • Weissig V, Pettinger TK, Murdock N. Nanopharmaceuticals (part 1): products on the market. Int J Nanomedicine. 2014;9:4357–4373.
  • Schütz CA, Juillerat-Jeanneret L, Mueller H, Lynch I, Riediker M. Therapeutic nanoparticles in clinics and under clinical evaluation. Nanomedicine. 2013;8:449–467.
  • Cevc G. Material transport across permeability barriers by means of lipid vesicles. In: Lipowsky R, Sackmann E, editors. Handbook of Biological Physics. Vol I. Netherlands: Elsevier Science BV; 1995:465–489.
  • Cevc G, Schätzlein A, Gebauer D, Blume G. Ultra-high efficiency of drug and peptide transfer through the intact skin by means of novel drug-carriers, transfersomes. In: Bain KR, Hadgkraft J, James WJ, Water KA, editors. Prediction of Percutaneous Penetration. Vol 3b. Cardiff: STS Publishing; 1993:226–234.
  • Brewer J, Bloksgaard M, Kubiak J, Sorensen JA, Bagatolli LA. Spatially resolved two-color diffusion measurements in human skin applied to transdermal liposome penetration. J Invest Dermatol. 2012;133:1260–1268.
  • Romero EL, Morilla MJ. Highly deformable and highly fluid vesicles as potential drug delivery systems: theoretical and practical considerations. Int J Nanomedicine. 2013;8:3171–3186.
  • Cevc G. Rational design of new product candidates: the next generation of highly deformable bilayer vesicles for noninvasive, targeted therapy. J Control Release. 2012;160:135–146.
  • Cevc G, Vierl U, inventors; Idea AG, assignee. NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery. United Sates patent US7473432 B2. January 6, 2009.
  • Cevc G, Vierl U, inventors; Idea AG, assignee. Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin. United Sates patent US20090155235 A1. June 18, 2009.
  • Van den Bergh BAI, Vroom J, Gerritsen H, Junginger HE, Bouwstra JA. Interactions of elastic and rigid vesicles with human skin in vitro: electron microscopy and two- photon excitation microscopy. Biochim Biophys Acta. 1999;1461:155–173.
  • Verma DD. Invasomes-novel topical carriers for enhanced topical delivery: characterization and skin penetration properties, PhD thesis, Marburg/Lahn, 2002.
  • van den Bergh BAI, Wertz PW, Junginger HE, Bouwstra JA. Elasticity of vesicles assessed by electron spin resonance, electron microscopy and extrusion measurements. Int J Pharm. 2001;217:13–24.
  • Elsayed MM, Cevc G. The vesicle-to-micelle transformation of phospholipid – cholate mixed aggregates: a state of the art analysis including membrane curvature effects. Biochim Biophys Acta. 2011;1808:140–153.
  • Batzri S, Korn ED. Single bilayer liposomes prepared without sonication. Biochim Biophys Acta. 1973;298:1015–1019.
  • Szoka F Jr, Papahadjopoulos D. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc Natl Acad Sci U S A. 1978;75:4194–4198.
  • Velegol SB, Logan BE. Contributions of bacterial surface polymers, electrostatics, and cell elasticity to the shape of AFM force curves. Langmuir. 2002;18:5256–5262.
  • Montanari J, Roncaglia D, Lado L, Morilla MJ, Romero EL. Avoiding failed reconstitution of ultradeformable liposomes upon dehydration. Int J Pharm. 2009;372:184–190.
  • Warner RR, Lilly NA. Correlation of water content with ultrastructure in the stratum corneum. In: Friedrich-Schiller PE, Berardesca E, Maibach HI, editors. Bioengineering of the Skin. Water and the Stratum Corneum, Volume I. Dermatology: Clinical and Basic Science Part No 6. Boca Raton, FL: Informa Healthcare; 1994:3–12.
  • Cevc G, Blume G. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim Biophys Acta. 1992;1104:226–232.
  • Cevc G, Gebauer D. Hydration-driven transport of deformable lipid vesicles through fine pores and the skin barrier. Biophys J. 2003;84:1010–1024.
  • Cevc G, Schätzlein A, Richardsen H. Ultradeformable lipid vesicles can penetrate the skin and other semi-permeable barriers unfragmented. Evidence from double label CLSM experiments and direct size measurements. Biochim Biophys Acta. 2002;1564:21–30.
  • Schätzlein A, Cevc G. Non-uniform cellular packing of the stratum corneum and permeability barrier function of intact skin: a high-resolution confocal laser scanning microscopy study using highly deformable vesicles (Transfersomes). Br J Dermatol. 1998;138:583–592.
  • Williams A. Transdermal and Topical Drug Delivery. 1st ed. London: Pharmaceutical Press; 2003.
  • Honeywell-Nguyen PL, de Graaff AM, Groenink HW, Bouwstra JA. The in vivo and in vitro interactions of elastic and rigid vesicles with human skin. Biochim Biophys Acta. 2002;1573:130–140.
  • Uchino T, Lefeber F, Gooris G, Bouwstra J. Characterization and skin permeation of ketoprofen-loaded vesicular systems. Eur J Pharm Biopharm. 2014;86:116–156.
  • Ntimenou V, Fahr A, Antimisiaris SG. Elastic vesicles for transdermal drug delivery of hydrophilic drugs: a comparison of important physicochemical characteristics of different vesicle types. J Biomed Nanotechnol. 2012;8:613–623.
  • Elsayed MMA, Abdallah OY, Naggar VF, Khalafallah NM. Lipid vesicles for skin delivery of drugs: reviewing three decades of research. Int J Pharm. 2007;332:1–16.
  • Cevc G, Blume G. Biological activity and characteristics of triamcinolone-acetonide formulated with the self-regulating drug carriers, transfersomes. Biochim Biophys Acta. 2003;1614:156–164.
  • Smyth EM, Grosser T, Wang M, Yu Y, FitzGerald GA. Prostanoids in health and disease. J Lipid Res. 2009;50:S423–S428.
  • Altman R, Asch E, Bloch D, et al. Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis Rheum. 1986;29(8):1039–1049.
  • Singh P, Roberts MS. Skin permeability and local tissue concentrations of non-steroidal anti-inflammatory drugs after topical application. J Pharmacol Exp Ther. 1994;268:144–151.
  • Hadgraft J, de Plessis J, Goosen C. The selection of non-steroidal anti- inflammatory agents for dermal delivery. Int J Pharm. 2000;207:31–37.
  • Patrono C, Rocca B. Nonsteroidal antiinflammatory drugs: past, present and future. Pharmacol Res. 2009;59:285–289.
  • Cevc G, Blume G. New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, transfersomes. Biochim Biophys Acta. 2001;1514:191–205.
  • Cevc G, Mazgareanu S, Rother M, Vierl U. Occlusion effect on transcutaneous NSAID delivery from conventional and carrier-based formulations. Int J Pharm. 2008;359:190–197.
  • Cevc G, Mazgareanu S, Rother M. Preclinical characterisation of NSAIDs in ultradeformable carriers or conventional topical gels. Int J Pharm. 2008;360:29–39.
  • Shaji J, Lal M. Preparation, optimization and evaluation of transferosomal formulation for enhanced transdermal delivery of a COX-2 inhibitor. Int J Pharm Pharm Sci. 2014;6:467–477.
  • Morris CR. Carrageenan-induced paw edema in the rat and mouse. In: Winyard PG, Willoughby DA, editors. Method in Molecular Biology. Inflammation Protocols. Vol 225. Totowa, NJ: Human Press Inc.; 2003:115–121.
  • Taha EI. Lipid vesicular systems: formulation optimization and ex vivo comparative study. J Mol Liquids. 2014;196:211–216.
  • Chaudhary H, Kohli K, Kumar V. Nano-transfersomes as a novel carrier for transdermal delivery. Int J Pharm. 2013;454:367–380.
  • Nava G, Piñón E, Mendoza L, Mendoza N, Quintanar D, Ganem A. Formulation and in vitro, ex vivo and in vivo evaluation of elastic liposomes for transdermal delivery of ketorolac tromethamine. Pharmaceutics. 2011;3:954–970.
  • Darsow U, Wollenberg A, Simon D, et al. ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis. JEADV. 2010;24:317–328.
  • Cevc G, Blume G, Schatzlein A. Transfersomes-mediated transepidermal delivery improves the regio- specificity and biological activity of corticosteroids in vivo. J Control Release. 1997;45:211–226.
  • Cevc G, Blume G. Hydrocortisone and dexamethasone in very deformable drug carriers have increased biological potency, prolonged effect, and reduced therapeutic dosage. Biochim Biophys Acta. 2004;1663:61–73.
  • Fesq H, Glöckner D, Abeck D, et al. Improved risk-benefit ratio for a triamcinolone acetonide transfersome formulation in comparison to a commercial triamcinolone acetonide formulation. Br J Dermatol. 2003;149:611–619.
  • Lei W, Yu C, Lin H, Zhou X. Development of tacrolimus-loaded transfersomes for deeper skin penetration enhancement and therapeutic effect improvement in vivo. Asian J Pharm Sci. 2013;8:336–345.
  • Li S, Qiu Y, Zhang S, Gao Y. Enhanced transdermal delivery of 18β-glycyrrhetic acid via elastic vesicles: in vitro and in vivo evaluation. Drug Dev Ind Pharm. 2012;38(7):855–865.
  • Goindi S, Kumar G, Kumar N, Kaur A. Development of novel elastic vesicle-based topical formulation of cetirizine dihydrochloride for treatment of atopic dermatitis. AAPS PharmSciTech. 2013;14:1284–1293.
  • Ahad A, Aqil M, Kohli K, Sultana Y, Mujeeb M, Ali A. Formulation and optimization of nanotransfersomes using experimental design technique for accentuated transdermal delivery of valsartan. Nanomedicine. 2012;8:237–249.
  • Yusuf M, Sharma V, Pathak K. Nanovesicles for transdermal delivery of felodipine: development, characterization, and pharmacokinetics. Int J Pharm Investig. 2014;4:119–130.
  • Tuon FF, Amato VS, Graf ME, Siqueira AM, Nicodemo AC, Amato Neto V. Treatment of new world cutaneous leishmaniasis – a systematic review with a meta-analysis. Int J Dermatol. 2008;47:109–124.
  • Lawn SD, Armstrong M, Chilton D, Whitty CJ. Electrocardiographic and biochemical adverse effects of sodium stibogluconate during treatment of cutaneous and mucosal leishmaniasis among returned travellers. Trans R Soc Trop Med Hyg. 2006;100:264–269.
  • Bavarsad N, Bazzaz BSF, Khamesipour A, Jaafari MR. Colloidal, in vitro and in vivo anti-leishmanial properties of transfersomes containing paromomycin sulfate in susceptible BALB/c mice. Acta Trop. 2012;124:33–41.
  • Carneiro G, Santos DC, Oliveira MC, et al. Topical delivery and in vivo antileishmanial activity of paromomycin loaded liposomes for treatment of cutaneous leishmaniasis. J Liposome Res. 2010;20:16–23.
  • Montanari J, Maidana C, Esteva MI, Salomon C, Morilla MJ, Romero EL. Sunlight triggered photodynamic ultradeformable liposomes against Leishmania braziliensis are also leishmanicidal in the dark. J Control Release. 2010;147:368–376.
  • Perez AP, Casasco A, Schilrreff P, et al. Enhanced photodynamic leishmanicidal activity of hydrophobic zinc phthalocyanine within archaeolipids containing liposomes. Int J Nanomedicine. 2014;9:3335–3345.
  • Darwhekar G, Jain DK, Choudhary A. Elastic liposomes for delivery of neomycin sulphate in deep skin infection. Asian J Pharm Sci. 2012;7:236–241.
  • Kumar R, Rana AC, Bala R, Seth N. Formulation and evaluation of elastic liposomes of clotrimazole. Int J Drug Dev Res. 2012;4(3):348–355.
  • Vanic Ž, Hafner A, Bego M, Škalko-Basnet N. Characterization of various deformable liposomes with metronidazole. Drug Dev Ind Pharm. 2013;39(3):481–488.
  • Cereda CM, Franz-Montan M, da Silva CM, et al. Transdermal delivery of butamben using elastic and conventional liposomes. J Liposome Res. 2013;23(3):228–234.
  • Liu D, Hub H, Lin Z, et al. Quercetin deformable liposome: preparation and efficacy against ultraviolet B induced skin damages in vitro and in vivo. J Photochem Photobiol B Biology. 2013;127:8–17.
  • Ascenso A, Salgado A, Euletério C, et al. In vitro and in vivo topical delivery studies of tretinoin-loaded ultradeformable vesicles. Eur J Pharm Biopharm. 2014;88(1):48–55.
  • Mahmood S, Taher M, Mandal UK. Experimental design and optimization of raloxifene hydrochloride loaded nanotransfersomes for transdermal application. Int J Nanomedicine. 2014;9:4331–4346.
  • Carrer DC, Higa LH, Defain Tesoriero MV, Morilla MJ, Roncaglia DI, Romero EL. Structural features of ultradeformable archaeosomes for topicaldelivery of ovalbumin. Colloids Surf B Biointerfaces. 2014;121:281–289.